Prof. Broich is a certified physician (neurology, psychiatry, cognitive behavioral therapy) and since 2014 President of the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn.

His current activities in the European network of regulatory authorities are Member of the Management Board of the European Medicines Agency (EMA MB), Chairman of the Net-work Portfolio Advisory Group (NPAG). He is a member of the Heads of Medicines Agencies (HMA) Management Group and is currently its Chair. Furthermore, he is co-chair of the Darwin EU Advisory Board of the EMA.

His scientific focus is on clinical psychopharmacology, imaging in neurodegenerative diseases and other potential biomarkers and dementia, and clinical trial methodology, among others. Prof. Karl Broich is author and co-author of more than 230 publications (original scientific papers, reviews, book contributions).